BioXcel Therapeutics shares pop after audit of Alzheimer's trial data

South Africa News News

BioXcel Therapeutics shares pop after audit of Alzheimer's trial data
South Africa Latest News,South Africa Headlines
  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 42 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 20%
  • Publisher: 97%

Audit findings support application for approval of treatment for Alzheimer’s-related agitation, company says

Shares of BioXcel Therapeutics Inc. BTAI, +0.86% jumped more than 40% premarket on Wednesday after the company said an independent audit of Alzheimer’s trial data found no issues impacting the data’s integrity and reliability.

The audit reviewed data from a single site of BioXcel’s late-stage trial of an experimental treatment for Alzheimer’s-related agitation in people 65 and older. Based on the audit findings, BioXcel said it believes that the phase 3 trial data it released in June may support a regulatory application for approval of the treatment, BXCL501.

Questions about the trial data arose in late June, when BioXcel said in a regulatory filing that it had learned that a principal investigator involved in the trial may have fabricated emails purporting to show that the investigator had submitted certain safety data in a timely fashion. The company said it promptly initiated an investigation and retained an independent third party to audit the data from the investigator’s trial site.BioXcel recently had a meeting with the U.S.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

MarketWatch /  🏆 3. in US

South Africa Latest News, South Africa Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

350 Horizon Therapeutics workers to be laid off, mostly from Deerfield offices, following acquisition by Amgen350 Horizon Therapeutics workers to be laid off, mostly from Deerfield offices, following acquisition by AmgenBiotechnology company Amgen acquired Horizon on Oct. 6
Read more »

Sen. Johnson to Newsmax: Biden Accounts Need Forensic AuditPresident Joe Biden's entangled foreign interests risk national security, Sen. Ron Johnson, R-Wis., who was one of the first to report about the story, told Newsmax on Tuesday.
Read more »

SBOA, Lake County officials set to meet Tuesday about unfinished auditSBOA, Lake County officials set to meet Tuesday about unfinished auditThe inability of the state body to complete its audit of the county prompted Standard & Poors to stop issuing the county a credit rating and led the SBOA to threaten to invoke new state statute that would allow for the state to hire accountants to take over the auditor’s or treasurer’s office or both because the records cannot audited.
Read more »

Walk to End Alzheimer's takes place this weekend at Reid Park in MidtownWalk to End Alzheimer's takes place this weekend at Reid Park in MidtownMore than 1,500 people are set to walk this Saturday, Oct. 28, to help fight a disease that affects more than 6 million people in the United States.
Read more »

Steven Weisberg, ‘Harry Potter and the Prisoner of Azkaban’ film editor, dead at 68Steven Weisberg, ‘Harry Potter and the Prisoner of Azkaban’ film editor, dead at 68The film editor was diagnosed with Alzheimer's when he was 55.
Read more »

Viagra could slash risk of Alzheimer's disease by 60%: studyViagra could slash risk of Alzheimer's disease by 60%: studySurprising, Side Effect of Taking Viagra, By Chris Kissell. Data on more than 7 million patients found taking sildenafil – which is sold under brand names like Viagra and Revatio — reduces the incidence of Alzheimer’s disease by 69%.
Read more »



Render Time: 2025-02-27 19:16:13